GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (OTCPK:BPTSY) » Definitions » Long-Term Debt

Biophytis (Biophytis) Long-Term Debt : $2.64 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Biophytis Long-Term Debt?

Biophytis's Long-Term Debt for the quarter that ended in Dec. 2023 was $2.64 Mil.

Biophytis's quarterly Long-Term Debt declined from Dec. 2022 ($3.72 Mil) to Jun. 2023 ($3.25 Mil) and declined from Jun. 2023 ($3.25 Mil) to Dec. 2023 ($2.64 Mil).

Biophytis's annual Long-Term Debt declined from Dec. 2021 ($4.96 Mil) to Dec. 2022 ($3.72 Mil) and declined from Dec. 2022 ($3.72 Mil) to Dec. 2023 ($2.64 Mil).

Biophytis Long-Term Debt Historical Data

The historical data trend for Biophytis's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Long-Term Debt Chart

Biophytis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.88 1.14 4.96 3.72 2.64

Biophytis Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.96 4.20 3.72 3.25 2.64

Biophytis  (OTCPK:BPTSY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biophytis Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biophytis's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biophytis (Biophytis) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (OTCPK:BPTSY) » Definitions » Long-Term Debt
Comparable Companies
XPAR:ALVET XPAR:ALMDP XPAR:ALQGC XPAR:ALTME XPAR:ALINT XPAR:ALPAT XPAR:ALTHX XPAR:ALNFL XPAR:ALNEV XPAR:ALPHA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
ALBPS:France 6XB:Germany
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Website
https://www.biophytis.com
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.